Koers Orthofix International NV Nasdaq
Aandelen
ANN6748L1027
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 793 mln. 742 mln. | Omzet 2025 * | 845 mln. 791 mln. | Marktkapitalisatie | 486 mln. 454 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -61 mln. -57,09 mln. | Nettowinst (verlies) 2025 * | -26 mln. -24,33 mln. | EV/omzet 2024 * | 0,61 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,57 x |
K/w-verhouding 2024 * |
-7,95
x | K/w-verhouding 2025 * |
-19
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,27% |
Recentste transcriptie over Orthofix International NV
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 52 | 08/01 | |
Julie Andrews
DFI | Director of Finance/CFO | 53 | 15/01 |
Chief Operating Officer | - | 01-01-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jason Hannon
BRD | Director/Board Member | 52 | 08-06-20 |
Charles Kummeth
BRD | Director/Board Member | 63 | 14/12 |
John Henneman
BRD | Director/Board Member | 62 | 05-01-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,61% | 184 mld. | |
-2,85% | 103 mld. | |
-4,87% | 67,59 mld. | |
+15,72% | 46,93 mld. | |
-8,91% | 43,87 mld. | |
+8,28% | 41,2 mld. | |
+17,11% | 30,47 mld. | |
+13,59% | 24,16 mld. | |
-7,28% | 23,57 mld. |